Building upon this previous work, we further extended our research to examine the protective capabilities of various doses of the S1PR-1/-5 modulator and ozanimod surrogate RP-101074 on retinal degeneration and visual function within the same LI-PRL model. Here, PRL is linked to retinal degeneration.